David M. Davies

2.7k total citations
34 papers, 1.9k citations indexed

About

David M. Davies is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, David M. Davies has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 19 papers in Immunology and 7 papers in Biomedical Engineering. Recurrent topics in David M. Davies's work include CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (9 papers). David M. Davies is often cited by papers focused on CAR-T cell therapy research (28 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (9 papers). David M. Davies collaborates with scholars based in United Kingdom, United States and Saudi Arabia. David M. Davies's co-authors include John Maher, Scott Wilkie, Sjoukje J. C. van der Stegen, S. Burbridge, Ana C. Parente‐Pereira, May CI van Schalkwyk, Lynsey M. Whilding, Stephen J. Mather, Julie Foster and Carol Box and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

David M. Davies

34 papers receiving 1.9k citations

Peers

Countries citing papers authored by David M. Davies

Since Specialization

Citations

This map shows the geographic impact of David M. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Davies more than expected).

Fields of papers citing papers by David M. Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Davies. The network helps show where David M. Davies may publish in the future.

Co-authorship network of co-authors of David M. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Davies. A scholar is included among the top collaborators of David M. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Davies. David M. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells 2024 ·Cell Reports Medicine ·(unknown), Daniel Larcombe-Young, (unknown), Fahima Kausar, Caroline Hull, (unknown), Ge Tan, Richard Beatson, (unknown), Roberta Mazza, (unknown), Chelsea Taylor, Andrea Billè, Katelyn M. Spillane, Domenico Cozzetto, Alessandra Vigilante, Anna Schurich, David M. Davies, John Maher	12
2	Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner 2024 ·Molecular Therapy ·Caroline Hull, Daniel Larcombe-Young, Roberta Mazza, (unknown), David M. Davies, Anna Schurich, John Maher	18
3	Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy 2024 ·Biology ·David M. Davies, Giuseppe Pugliese, (unknown), Lynsey M. Whilding, Daniel Larcombe-Young, John Maher	2
4	CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets 2023 ·Cancers ·John Maher, David M. Davies	17
5	CAR Based Immunotherapy of Solid Tumours—A Clinically Based Review of Target Antigens 2023 ·Biology ·John Maher, David M. Davies	14
6	Generation and application of TGFβ-educated human Vγ9Vδ2 T cells 2022 ·STAR Protocols ·Ana C. Parente‐Pereira, Richard Beatson, David M. Davies, Caroline Hull, Lynsey M. Whilding, Joanna C. Porter, John Maher	3
7	Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation 2022 ·Frontiers in Immunology ·Leena Halim, Kushal Kumar Das, Daniel Larcombe-Young, (unknown), Andrea Candelli, Reuben Benjamin, Richard Dillon, David M. Davies, John Maher	19
8	Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors 2021 ·Cell Reports Medicine ·Paris Kosti, James W. Opzoomer, (unknown), Rhonda Henley‐Smith, Cheryl L. Scudamore, (unknown), (unknown), David M. Davies, Tamara Muliaditan, Daniel Larcombe-Young, Natalie Woodman, Cheryl Gillett, Selvam Thavaraj, John Maher, James N. Arnold	111
9	Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer 2020 ·Clinical & Experimental Immunology ·(unknown), David M. Davies, John Maher	21
10	CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies 2019 ·Cancers ·Lynsey M. Whilding, Leena Halim, Benjamin Draper, Ana C. Parente‐Pereira, Tomasz Zabinski, David M. Davies, John Maher	166
11	CAR T-cell immunotherapy of MET-expressing malignant mesothelioma 2017 ·OncoImmunology ·(unknown), Roseanna M. Petrovic, Daniela Achkova, Tomasz Zabinski, David M. Davies, Astero Klampatsa, Ana C. Parente‐Pereira, Lynsey M. Whilding, (unknown), Natalie Woodman, Michael Sheaff, Jennifer R. Cochran, James Spicer, John Maher	52
12	Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells 2017 ·Cancer Letters ·Astero Klampatsa, Daniela Achkova, David M. Davies, Ana C. Parente‐Pereira, Natalie Woodman, (unknown), (unknown), (unknown), Andrea Billè, (unknown), James Spicer, Juliet King, John Maher	52
13	Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells 2017 ·Molecular Therapy ·Lynsey M. Whilding, Ana C. Parente‐Pereira, Tomasz Zabinski, David M. Davies, Roseanna M. Petrovic, (unknown), Shobhit Saxena, (unknown), (unknown), Shelia M. Violette, Hiroaki Itamochi, Sadaf Ghaem‐Maghami, Sabari Vallath, John F. Marshall, John Maher	69
14	The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development 2017 ·Frontiers in Immunology ·(unknown), Angélica Cuapio, (unknown), (unknown), Ulrike Resch, David M. Davies, Martin Bilban, (unknown), Wolfgang Eppel, Amit Nathwani, Dagmar Stoiber, Jan Spanholtz, Emilio Casanova, Erhard Hofer	33
15	Abstract CT118: T4 immunotherapy of head and neck squamous cell carcinoma using pan-ErbB targeted CAR T-cells 2017 ·Cancer Research ·Sophie Papa, Antonella Adami, (unknown), Daniela Achkova, May CI van Schalkwyk, (unknown), Leticia Bosshard‐Carter, Lynsey M. Whilding, (unknown), David M. Davies, Teresa Guerrero Urbano, Jean‐Pierre Jeannon, James Spicer, John Maher	5
16	Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells 2012 ·Molecular Medicine ·David M. Davies, Julie Foster, Sjoukje J. C. van der Stegen, Ana C. Parente‐Pereira, Laura Chiapero-Stanke, (unknown), S. Burbridge, (unknown), Zhe Liu, Leticia Bosshard‐Carter, May CI van Schalkwyk, Carol Box, Suzanne A. Eccles, Stephen J. Mather, Scott Wilkie, John Maher	95
17	Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice 2011 ·Journal of Clinical Immunology ·Ana C. Parente‐Pereira, Jerome Burnet, David H. Ellison, Julie Foster, David M. Davies, (unknown), S. Burbridge, Laura Chiapero-Stanke, Scott Wilkie, Stephen J. Mather, John Maher	87
18	Adoptive T-cell Immunotherapy of Cancer Using Chimeric Antigen Receptor-Grafted T Cells 2010 ·Archivum Immunologiae et Therapiae Experimentalis ·David M. Davies, John Maher	12
19	Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4 2010 ·Journal of Biological Chemistry ·Scott Wilkie, S. Burbridge, Laura Chiapero-Stanke, (unknown), Siobhán Cleary, Sjoukje J. C. van der Stegen, James Spicer, David M. Davies, John Maher	157
20	A suggested use of homografts. 1963 ·PubMed ·(unknown), David M. Davies, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact